Gerszten RE - Search Results

1

The genetic architecture of plasma kynurenine includes cardiometabolic disease mechanisms associated with the SH2B3 gene.

Bagheri M, Wang C, Shi M, Manouchehri A, Murray KT, Murphy MB, Shaffer CM, Singh K, Davis LK, Jarvik GP, Stanaway IB, Hebbring S, Reilly MP, Gerszten RE, Wang TJ, Mosley JD, Ferguson JF. Bagheri M, et al. Among authors: gerszten re. Sci Rep. 2021 Aug 2;11(1):15652. doi: 10.1038/s41598-021-95154-9. Sci Rep. 2021. PMID: 34341450 Free PMC article.

2

The search for new cardiovascular biomarkers.

Gerszten RE, Wang TJ. Gerszten RE, et al. Nature. 2008 Feb 21;451(7181):949-52. doi: 10.1038/nature06802. Nature. 2008. PMID: 18288185 Review.

3

Novel antibody markers of unstable atherosclerotic lesions.

Bloch DB, Wang TJ, Gerszten RE. Bloch DB, et al. Among authors: gerszten re. J Clin Invest. 2008 Aug;118(8):2675-7. doi: 10.1172/JCI36270. J Clin Invest. 2008. PMID: 18654669 Free PMC article.

4

New antibody assays for cardiovascular disease: future tools for the clinical chemist?

Gerszten RE, Sabatine M, Wang TJ. Gerszten RE, et al. Clin Chem. 2009 Mar;55(3):404-6. doi: 10.1373/clinchem.2008.118646. Epub 2009 Jan 23. Clin Chem. 2009. PMID: 19168551 No abstract available.

5

Two roads diverge: weight loss interventions and circulating amino acids.

Gerszten RE, Wang TJ. Gerszten RE, et al. Sci Transl Med. 2011 Apr 27;3(80):80ps15. doi: 10.1126/scitranslmed.3002377. Sci Transl Med. 2011. PMID: 21525396

6

Metabolite profiling identifies pathways associated with metabolic risk in humans.

Cheng S, Rhee EP, Larson MG, Lewis GD, McCabe EL, Shen D, Palma MJ, Roberts LD, Dejam A, Souza AL, Deik AA, Magnusson M, Fox CS, O'Donnell CJ, Vasan RS, Melander O, Clish CB, Gerszten RE, Wang TJ. Cheng S, et al. Among authors: gerszten re. Circulation. 2012 May 8;125(18):2222-31. doi: 10.1161/CIRCULATIONAHA.111.067827. Epub 2012 Apr 11. Circulation. 2012. PMID: 22496159 Free PMC article.

7

Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes.

Walford GA, Porneala BC, Dauriz M, Vassy JL, Cheng S, Rhee EP, Wang TJ, Meigs JB, Gerszten RE, Florez JC. Walford GA, et al. Among authors: gerszten re. Diabetes Care. 2014 Sep;37(9):2508-14. doi: 10.2337/dc14-0560. Epub 2014 Jun 19. Diabetes Care. 2014. PMID: 24947790 Free PMC article.

8

Dimethylglycine Deficiency and the Development of Diabetes.

Magnusson M, Wang TJ, Clish C, Engström G, Nilsson P, Gerszten RE, Melander O. Magnusson M, et al. Among authors: gerszten re. Diabetes. 2015 Aug;64(8):3010-6. doi: 10.2337/db14-1863. Epub 2015 Mar 20. Diabetes. 2015. PMID: 25795213 Free PMC article.

9

Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention Program.

Walford GA, Ma Y, Clish C, Florez JC, Wang TJ, Gerszten RE; Diabetes Prevention Program Research Group. Walford GA, et al. Among authors: gerszten re. Diabetes. 2016 May;65(5):1424-33. doi: 10.2337/db15-1063. Epub 2016 Feb 9. Diabetes. 2016. PMID: 26861782 Free PMC article. Clinical Trial.

10

Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes.

Ho JE, Larson MG, Ghorbani A, Cheng S, Chen MH, Keyes M, Rhee EP, Clish CB, Vasan RS, Gerszten RE, Wang TJ. Ho JE, et al. Among authors: gerszten re. PLoS One. 2016 Feb 10;11(2):e0148361. doi: 10.1371/journal.pone.0148361. eCollection 2016. PLoS One. 2016. PMID: 26863521 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

320 results

Search Page